XML 52 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2022
Derivative Financial Instruments  
Amounts related to cumulative basis adjustments for fair value hedges

    

March 31, 

    

December 31, 

 

(Dollars in millions)

2022

2021

 

Short-term debt:

 

  

 

  

Carrying amount of the hedged item

$

(225)

$

(227)

Cumulative hedging adjustments included in the carrying amount — assets/(liabilities)

 

0

 

(2)

Long-term debt:

 

  

 

  

Carrying amount of the hedged item

$

(2,480)

$

(508)

Cumulative hedging adjustments included in the carrying amount — assets/(liabilities)*

 

(290)

 

(309)

* Includes ($289) million and ($302) million of hedging adjustments on discontinued hedging relationships at March 31, 2022 and December 31, 2021, respectively.

Effect of derivative instruments in the Consolidated Income Statement

Gains/(Losses) of

 

(Dollars in millions)

Total

Total Hedge Activity

 

For the three months ended March 31:

    

2022

    

2021

    

2022

    

2021

 

Cost of services

$

5,349

$

4,644

$

15

$

14

Cost of sales

 

1,415

 

1,379

*

 

12

 

(22)

Cost of financing

 

98

 

137

*

 

(2)

 

2

SG&A expense

 

4,597

 

4,688

 

(70)

 

34

Other (income) and expense

 

246

 

346

 

(102)

 

(160)

Interest expense

 

311

 

280

 

(6)

 

5

* Reclassified to conform to current year presentation.

Gain (Loss) Recognized in Consolidated Income Statement

Consolidated

Recognized on

Attributable to Risk

(Dollars in millions)

Income Statement

Derivatives

Being Hedged (2)

For the three months ended March 31:

    

Line Item

    

2022

    

2021

    

2022

    

2021

Derivative instruments in fair value hedges (1):

 

  

 

  

 

  

 

  

 

  

Interest rate contracts

 

Cost of financing

$

(1)

$

(1)

$

4

$

7

 

Interest expense

 

(4)

 

(1)

 

16

 

18

Derivative instruments not designated as hedging instruments:

 

  

 

  

 

  

 

  

 

  

Foreign exchange contracts

 

Other (income) and expense

 

(95)

 

(44)

 

N/A

 

N/A

Equity contracts

 

SG&A expense

 

(76)

 

49

 

N/A

 

N/A

Total

 

  

$

(176)

$

3

$

20

$

25

Gain (Loss) Recognized in Consolidated Income Statement and Other Comprehensive Income

 

(Dollars in millions)

Consolidated

Reclassified

Amounts Excluded from

 

For the three months

Recognized in OCI

Income Statement

from AOCI

Effectiveness Testing (3)

 

ended March 31:

    

2022

    

2021

    

Line Item

    

2022

    

2021

    

2022

    

2021

 

Derivative instruments in cash flow hedges:

 

  

 

  

 

  

 

  

 

  

  

 

  

Interest rate contracts

$

$

 

Cost of financing

$

(1)

$

(1)

$

$

 

Interest expense

 

(3)

 

(3)

 

 

Foreign exchange contracts

 

60

 

187

 

Cost of services

 

15

 

14

 

 

 

Cost of sales

 

12

 

(22)

 

 

 

Cost of financing

 

(5)

 

(5)

 

SG&A expense

 

6

 

(15)

 

 

 

Other (income) and expense

 

(7)

 

(116)

 

 

 

Interest expense

 

(17)

 

(13)

Instruments in net investment hedges (4):

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Foreign exchange contracts

 

541

 

907

 

Cost of financing

 

 

 

1

 

2

 

 

 

Interest expense

 

 

 

2

 

4

Total

$

601

$

1,094

 

  

$

1

$

(160)

$

3

$

6

(1)The amount includes changes in clean fair values of the derivative instruments in fair value hedging relationships and the periodic accrual for coupon payments required under these derivative contracts.
(2)The amount includes basis adjustments to the carrying value of the hedged item recorded during the period and amortization of basis adjustments recorded on de-designated hedging relationships during the period.
(3)The company’s policy is to recognize all fair value changes in amounts excluded from effectiveness testing in net income each period.
(4)Instruments in net investment hedges include derivative and non-derivative instruments with the amounts recognized in OCI providing an offset to the translation of foreign subsidiaries.

N/A - not applicable